Prostate cancer risk and consumption of fish oils: A dietary biomarker-based case-control study

British Journal of Cancer

Volumn 81, Issue 7, 1999, Pages 1238-1242

  Norrish, A E ^a   Skeaff, C M ^b   Arribas, G L B ^b   Sharpe, S J ^a   Jackson, R T ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Biomarker; Diet; Docosahexaenoic acid; Eicosapentaenoic acid; Prostatic neoplasms

Indexed keywords

DOCOSAHEXAENOIC ACID; FISH OIL; ICOSAPENTAENOIC ACID; PHOSPHATIDYLCHOLINE;

ADULT; AGED; ARTICLE; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; ERYTHROCYTE; HUMAN; HUMAN CELL; LIPID DIET; MAJOR CLINICAL STUDY; MALE; NEW ZEALAND; PRIORITY JOURNAL; PROSTATE CANCER;

EID: 0032755780     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6690835     Document Type: Article

References (30)

1. Agren JJ and Hanninen OO (1991) Effect of moderate freshwater fish diet on erythrocyte ghost phospholipid fatty acids. Ann Med 23: 261-263
2. Baro L, Hermoso J-C, Nunez M-C, Jiminenez-Rios J-A and Gil A (1998) Abnormalities in plasma and red blood cell fatty acid profiles of patients with colorectal cancer. Br J Cancer 77: 1978-1983
3. Bligh DG and Dyer WJ (1959) A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37: 911-917
4. Brown AJ, Pang E and Roberts DC (1991) Persistent changes in the fatty acid composition of erythrocyte membrance after moderate intake of n-3 polyunsaturated fatty acids: study design implications. Am J Clin Nutr 54: 668-673
5. Burlingame BA, Milligan GC, Apimerika DE and Arthur JM (1993) The Concise New Zealand Food Composition Tables. Palmerston North, NZ: New Zealand Institute for Crop and Food Research Limited, Department of Health
6. Chaudry AA, Wahle KWJ, McClinton S and Moffat LEP (1994) Arachidonic acid metabolism in benign and malignant prostatic tissue in vitro: effects of fatty acids and cyclooxygenase inhibitors. Int J Cancer 57: 176-180
7. Earnest DL, Hixson LJ and Alberts DS (1992) Piroxicam and other cyclooxygenase inhibitors: potential for cancer chemoprevention. J Cell Biochem 161 (suppl): 156-166
8. Ewings P and Bowie C (1996) A case-control study of cancer of the prostate in Somerset and East Devon. Br J Cancer 74: 661-666
9. Gann PH, Hennekens FM, Sacks FG, Grodstein F, Giovannucci EL and Stampfer MJ (1994) Prospective study of plasma fatty acids and risk of prostate cancer. J Natl Cancer Inst 86: 281-286
10. Giovannucci E (1995) Epidemiological characteristics of prostate cancer. Cancer 75: 1766-1777
11. Giovannucci E, Rimm EB, Colditz GA, Stampfer MJ, Asherio A, Chute CC and Willett WC (1992) A prospective study of dietary fat and risk of prostate cancer. J Natl Cancer Inst 85: 1571-1579
12. Glatz JFC, Soffers AE and Katan MB (1989) Fatty acid composition of serum cholesterol esters and erythrocyte membranes as indicators of linoleic acid intake in man. Am J Clin Nutr 49: 269-276
13. Godley PA, Campbell MK, Miller C, Gallagher P, Martinson FE, Mohler JL and Sandler RS (1996a) Correlation between biomarkers of omega-3 fatty acid consumption and questionnaire data in African American and Caucasian United States males with and without prostatic carcinoma. Cancer Epidemiol Biomarkers Prev 5: 115-119
14. Godley PA, Campbell MK, Gallagher P, Martinson FEA, Mohler JL and Sandler RS (1996b) Biomarkers of essential fatty acid consumption and risk of prostatic carcinoma. Cancer Epidemiol Biomarkers Prev 5: 889-895
15. Harvei S, Bjerve KS, Tretli S, Jellum E, Robsahm TE and Vatten L (1997) Prediagnostic level of fatty acids in serum phospholipids: Ω-3 and Ω-6 fatty acids and the risk of prostate cancer. Int J Cancer 71: 545-551
16. Holub BJ and Skeaff CM (1987) Nutritional regulation of cellular phosphatidylinositol. Methods Enzymol 141: 234-244
17. Johnston R (1983) A Revision of Socio-economic Indices for New Zealand. New Zealand Council for Educational Research: Wellington
18. Karmali RA (1987) Fatty acids: inhibition. Am J Clin Nutr 45: 225-229
19. Kolonel LN (1996) Nutrition and prostate cancer. Cancer Causes Control 7: 83-94
20. Lupulescu A (1996) Prostaglandins, their inhibitors and cancer. Prostaglandins Leuko Essent Fatty Acids 54: 83-94
21. Mishina T, Watanabe H, Araki H and Nakao M (1985) Epidemiological study of prostatic cancer by matched pair analysis. Prostate 6: 423-436
22. Mantzioris E, James MJ, Gibson RA and Cleland LG (1994) Dietary substitution with an alpha-linolenic acid rich vegetable oil increases cicosapentaenoic acid concentrations in tissues. Am J Clin Nutr 59: 1304-1309
23. Nomura AM and Kolonel LN (1991) Prostate cancer: a current perspective. Am J Epidemiol 139: 200-227
24. Norrish AE, Jackson RT and McRae CU (1998) Non-steroidal anti-inflammatory drugs and prostate cancer progression. Int J Cancer 77: 511-515
25. Pandalai PK, Pilat MJ, Yumazaki K, Naik H and Pienta KJ (1996) The effects of omega-3 and omega-6 fatty acids on in vitro prostate cancer growth. Anticancer Res 16: 815-820
26. Rose DP (1997) Effects of dietary fatty acids on breast and prostate cancers: evidence from in vitro experiments and animal studies. Am J Clin Nutr 66 (suppl): 1513S-1522S
27. Rose DP and Connolly JM (1991) Effects of fatty acids and eicosanoid synthesis on the growth of two prostate cancer cell lines. Prostate 18: 243-254
28. Sanders TA and Roshanai F (1983) The influence of different types of omega 3 polyunsaturated fatty acids on blood lipids and platelet function in healthy volunteers. Clinical Science 64: 91-99
29. Sharpe SJ, Page NA, Gamble GD and Sharpe CM (1993) Validation of a food frequency questionnaire for use in cardiovascular risk factor studies in New Zealand. Proc Nut Soc NZ 18: 90-100
30. Vajreswari A and Narayanareddy K (1992) Effect of dietary fats on erythrocyte membrane lipid composition acid membrane-bound enzyme activities. Metabolism 41: 352-358